insomnia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Meet the diagnostic criteria for insomnia of the cardio-renal dysfunction type; (2) Age =18 and =65 years old, gender is not limited; (3) Stabilized on sedative-hypnotic drugs for more than 3 months or no drugs before entering this study; (4) PSQI score >5 and <21, belonging to mild to moderate insomnia; (5) Voluntarily participated in this trial and signed an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with comorbid cardiac, hepatic, renal, hematopoietic, endocrine, tuberculosis, tumors, and other serious primary diseases, as well as infectious and contagious diseases; (2) With severe or unstable psychopathology or cognitive impairment/dementia; (3) Those with skin breakdown in the ear; (4) Patients with sleep disorders such as sleep apnea, restless legs syndrome, and circadian rhythm sleep disorders; (5) People with bad lifestyle habits such as alcohol or drug abusers; (6) Women during pregnancy or lactation; (7) Participated or are participating in other clinical research trials within the last 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pittsburgh Sleep Quality Index;Beck Anxiety Inventory;Beck Depression Inventory; | — |
Secondary
| Measure | Time frame |
|---|---|
| Insomnia Severity Index;Traditional Chinese Medicine Syndrome Score Scale;Epworth Sleepiness Scale; | — |
Countries
China
Contacts
Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine, Shanghai University of Traditional Chinese Medicine